Financhill
Sell
20

ADAP Quote, Financials, Valuation and Earnings

Last price:
$0.59
Seasonality move :
36.97%
Day range:
$0.59 - $0.61
52-week range:
$0.47 - $2.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.85x
P/B ratio:
1.93x
Volume:
3.1M
Avg. volume:
2.7M
1-year change:
37.05%
Market cap:
$154.8M
Revenue:
$60.3M
EPS (TTM):
-$0.18

Adaptimmune Therapeutics PLC SEC Filings

Company Filed Form Type Description
ADAP
Adaptimmune Therapeutics PLC
11/08/2023 10-Q 10-Q filing on 11/08/2023 View Form
ADAP
Adaptimmune Therapeutics PLC
08/09/2023 10-Q 10-Q filing on 08/09/2023 View Form
ADAP
Adaptimmune Therapeutics PLC
05/12/2023 10-Q 10-Q filing on 05/12/2023 View Form
ADAP
Adaptimmune Therapeutics PLC
11/08/2022 10-Q 10-Q filing on 11/08/2022 View Form
ADAP
Adaptimmune Therapeutics PLC
08/04/2022 10-Q 10-Q filing on 08/04/2022 View Form
ADAP
Adaptimmune Therapeutics PLC
05/09/2022 10-Q 10-Q filing on 05/09/2022 View Form
ADAP
Adaptimmune Therapeutics PLC
11/04/2021 10-Q 10-Q filing on 11/04/2021 View Form
ADAP
Adaptimmune Therapeutics PLC
08/09/2021 10-Q 10-Q filing on 08/09/2021 View Form
ADAP
Adaptimmune Therapeutics PLC
05/06/2021 10-Q 10-Q filing on 05/06/2021 View Form
ADAP
Adaptimmune Therapeutics PLC
11/05/2020 10-Q 10-Q filing on 11/05/2020 View Form
ADAP
Adaptimmune Therapeutics PLC
08/06/2020 10-Q 10-Q filing on 08/06/2020 View Form
ADAP
Adaptimmune Therapeutics PLC
05/28/2020 10-Q 10-Q filing on 05/28/2020 View Form
ADAP
Adaptimmune Therapeutics PLC
05/14/2020 10-Q 10-Q filing on 05/14/2020 View Form
ADAP
Adaptimmune Therapeutics PLC
02/27/2020 10-K 10-K filing on 02/27/2020 View Form
ADAP
Adaptimmune Therapeutics PLC
11/06/2019 10-Q 10-Q filing on 11/06/2019 View Form
ADAP
Adaptimmune Therapeutics PLC
08/01/2019 10-Q 10-Q filing on 08/01/2019 View Form
ADAP
Adaptimmune Therapeutics PLC
05/06/2019 10-Q 10-Q filing on 05/06/2019 View Form
ADAP
Adaptimmune Therapeutics PLC
02/27/2019 10-K 10-K filing on 02/27/2019 View Form
ADAP
Adaptimmune Therapeutics PLC
11/06/2018 10-Q 10-Q filing on 11/06/2018 View Form
ADAP
Adaptimmune Therapeutics PLC
08/02/2018 10-Q 10-Q filing on 08/02/2018 View Form
ADAP
Adaptimmune Therapeutics PLC
05/09/2018 10-Q 10-Q filing on 05/09/2018 View Form
ADAP
Adaptimmune Therapeutics PLC
03/15/2018 10-K 10-K filing on 03/15/2018 View Form
ADAP
Adaptimmune Therapeutics PLC
11/02/2017 10-Q 10-Q filing on 11/02/2017 View Form
ADAP
Adaptimmune Therapeutics PLC
08/03/2017 10-Q 10-Q filing on 08/03/2017 View Form
ADAP
Adaptimmune Therapeutics PLC
05/10/2017 10-Q 10-Q filing on 05/10/2017 View Form
ADAP
Adaptimmune Therapeutics PLC
04/06/2017 10-Q 10-Q filing on 04/06/2017 View Form
ADAP
Adaptimmune Therapeutics PLC
03/13/2017 10-K 10-K filing on 03/13/2017 View Form
ADAP
Adaptimmune Therapeutics PLC
11/10/2016 10-Q 10-Q filing on 11/10/2016 View Form
ADAP
Adaptimmune Therapeutics PLC
08/08/2016 10-Q 10-Q filing on 08/08/2016 View Form
ADAP
Adaptimmune Therapeutics PLC
05/12/2016 10-Q 10-Q filing on 05/12/2016 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is down 0.24% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 5% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.65% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock